Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
600MPE
HR+
Luminal
ICRF-193
TOP2
TOP
12224.157
uM
inf
inf
0.6710 0.6710 0.0000 0.1152
0.3373
1.0737
600MPE
HR+
Luminal
Nilotinib
ABL
nRTK
12224.145
uM
inf
inf
0.9894 0.9894 0.0000 -0.0249
-0.6099
0.9737
BT-20
TNBC
Basal A
AG1024
IGF1R
RTK
5902.066
uM
inf
inf
0.9990 0.9990 0.0000 -0.0235
-0.9254
1.1775
AU565
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5900.085
uM
inf
inf
0.5199 0.5199 0.0000 0.0667
0.2964
2.6391
BT-20
TNBC
Basal A
Dichloroacetate
PDK
PDK
13579.176
uM
inf
inf
0.8837 0.8837 0.0000 -0.0031
0.4777
0.7690
BT-474
HER2amp
Luminal
CPT-11
TOP1
TOP
7798.077
uM
inf
inf
0.8883 0.8883 0.0000 -0.0257
0.4190
1.4371
600MPE
HR+
Luminal
GM6001
MMP
MMP
5898.096
uM
inf
inf
0.8794 0.8794 0.0000 0.0460
-0.0341
0.6718
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12178.155
uM
inf
inf
0.7358 0.7358 0.0000 0.2219
0.0157
0.8489
600MPE
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12224.154
uM
inf
inf
0.7982 0.7982 0.0000 0.0654
0.1825
0.9590
BT-474
HER2amp
Luminal
PD184352
MEK
MAPK
12291.155
uM
inf
inf
0.8808 0.8808 0.0000 -0.0271
-0.2848
0.4532
600MPE
HR+
Luminal
Dichloroacetate
PDK
PDK
13091.176
uM
inf
inf
0.9717 0.9717 0.0000 0.0439
-0.10
0.8746
21MT-1
HER2amp
-
Dichloroacetate
PDK
PDK
13719.176
uM
inf
inf
0.9233 0.9233 0.0000 0.0596
-0.2426
0.8672
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5899.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0165
0.0780
0.7056
BT-474
HER2amp
Luminal
TCS PIM-1 1
Pim kinase
PIM
12178.135
uM
inf
inf
0.9217 0.9217 0.0000 -0.0119
0.2808
0.5524
BT-474
HER2amp
Luminal
GM6001
MMP
MMP
5905.096
uM
inf
inf
0.3979 0.3979 0.0000 0.1096
0.2122
0.9091
184A1
NM
Basal
Trastuzumab
HER2
ErbB
9047.026
uM
inf
inf
0.2837 0.2837 0.0000 0.2170
0.0804
0.5972
BT-20
TNBC
Basal A
TCS PIM-1 1
Pim kinase
PIM
11854.135
uM
inf
inf
0.8384 0.8384 0.0000 0.0710
0.5319
1.3170
BT-474
HER2amp
Luminal
GSK461364
PLK1
PLK
9158.001
uM
inf
inf
-0.9965 -0.9965 0.0000 0.3194
0.2618
0.6988
BT-474
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
12056.154
uM
inf
inf
0.7002 0.7002 0.0000 0.2152
-0.1183
0.9136
AU565
HER2amp
Luminal
Trametinib
MEK
MAPK
7793.012
uM
inf
inf
1.0078 1.0078 0.0000 -0.0215
-0.0764
1.1030
600MPE
HR+
Luminal
Ixabepilone
TUBB
TUBB
5899.094
uM
inf
inf
-0.9801 -0.9801 0.0000 0.9711
0.3677
1.0334
BT-20
TNBC
Basal A
Selumetinib
MEK
MAPK
11854.155
uM
inf
inf
0.9135 0.9135 0.0000 0.0714
0.3056
1.3396
600MPE
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
12224.072
uM
inf
inf
0.8349 0.8349 0.0000 0.1299
-0.0188
1.0105
CAMA-1
HR+
Luminal
PD184352
MEK
MAPK
12070.155
uM
inf
inf
0.8551 0.8551 0.0000 0.0592
-0.0020
1.1729
CAMA-1
HR+
Luminal
PD184352
MEK
MAPK
12070.155
uM
inf
inf
0.8551 0.8551 0.0000 0.0592
-0.0020
1.1729